Literature DB >> 12576359

Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects.

Sheldon T Brown1, Ian Brett, Peter L Almenoff, Marvin Lesser, Michael Terrin, Alvin S Teirstein.   

Abstract

STUDY
OBJECTIVE: To determine if cell wall-deficient forms (CWDF) of mycobacteria can be grown in culture of blood from subjects with sarcoidosis.
DESIGN: A special multicenter study of sarcoidosis (A Case Control Etiologic Study of Sarcoidosis), supported by the National Heart, Lung, and Blood Institute. PATIENTS AND CONTROL
SUBJECTS: PATIENTS AND CONTROL SUBJECTS were recruited at 10 institutions in the United States. Control subjects (controls) were of the same gender and race, and within 5 years of age as matching patients with sarcoidosis (cases).
RESULTS: Cultures were incubated from 347 blood specimens (197 cases, 150 controls). Two investigators trained to recognize CWDF mycobacteria examined material obtained from culture tubes after 3 weeks. Structures thought to be CWDF were seen with equal frequency in cases (38%) and controls (41%). Thirty-nine percent of cases and 37% of controls were read as negative for CWDF.
CONCLUSION: This study fails to confirm earlier reports that CWDF mycobacteria can be grown from the blood of patients with sarcoidosis, but not from control subjects.

Entities:  

Mesh:

Year:  2003        PMID: 12576359     DOI: 10.1378/chest.123.2.413

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

Review 2.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

Review 3.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

4.  Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.

Authors:  M I Gabrilovich; J Walrath; J van Lunteren; D Nethery; M Seifu; J A Kern; C V Harding; L Tuscano; H Lee; S D Williams; W Mackay; J F Tomashefski; R F Silver
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 5.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

6.  Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis.

Authors:  Chuling Fang; Hui Huang; Zuojun Xu
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

7.  Childhood sarcoidosis: A rare but fascinating disorder.

Authors:  Avinash K Shetty; Abraham Gedalia
Journal:  Pediatr Rheumatol Online J       Date:  2008-09-23       Impact factor: 3.054

Review 8.  Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methods.

Authors:  Jeannette Guarner
Journal:  Scientifica (Cairo)       Date:  2012-12-31

Review 9.  [Epidemiology of sarcoidosis].

Authors:  Estrella Fernández Fabrellas
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.